Live Quiz Arena
🎁 1 Free Round Daily
⚡ Enter ArenaQuestion
← Human Body & HealthA patient with a genetic mutation has normal levels of prothrombin but their blood clots slowly. Which mechanism explains this phenomenon in hemostasis?
A)Increased thromboxane A2 production
B)Defective platelet aggregation response
C)Impaired thrombin-to-fibrin conversion✓
D)Elevated plasminogen activator inhibitor
💡 Explanation
The delayed clotting suggests a problem in the later stages of the coagulation cascade, because prothrombin converts to thrombin, which then converts fibrinogen to fibrin. Therefore, an impaired thrombin-to-fibrin conversion explains the slow clotting, rather than issues with platelet aggregation or initial activation factors.
🏆 Up to £1,000 monthly prize pool
Ready for the live challenge? Join the next global round now.
*Terms apply. Skill-based competition.
Related Questions
Browse Human Body & Health →- A patient with Von Willebrand disease experiences prolonged bleeding after a minor injury. Which mechanism is impaired, resulting in this extended bleeding time?
- Which consequence results when placental apoptotic signaling increases beyond homeostatic limits?
- Why does the ileum, rather than the stomach, primarily absorb digested fats despite both being part of the digestive system?
- If a patient with chronic anemia experiences a sudden decrease in 2,3-BPG levels, which consequence follows regarding oxygen transport?
- Why does enteric nervous system (ENS) activation during digestion cause increased intestinal motility in the small intestine rather than decreased motility?
- What causes reduced sensation of fullness after eating in obese individuals with leptin resistance?
